HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

vasostatin

N-terminal domain of calreticulin inclusive of amino acids 1-180; an angiogenesis inhibitor that exerts antitumor effects in vivo
Also Known As:
calreticulin N-terminal peptide 120-180
Networked: 33 relevant articles (7 outcomes, 12 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Szala, Stanisław: 3 articles (01/2012 - 01/2006)
2. Jarosz, Magdalena: 3 articles (01/2012 - 01/2006)
3. Jazowiecka-Rakus, Joanna: 3 articles (01/2012 - 01/2006)
4. Tai, Ming-Hong: 3 articles (01/2009 - 01/2005)
5. Tosato, Giovanna: 3 articles (01/2007 - 01/2002)
6. Sochanik, Aleksander: 2 articles (01/2012 - 01/2007)
7. Sheu, Shwu-Jiuan: 2 articles (01/2009 - 12/2005)
8. Lin, Hsiu-Chen: 2 articles (01/2009 - 12/2005)
9. Bee, Youn-Shen: 2 articles (01/2009 - 12/2005)
10. Xu, Ruian: 2 articles (11/2008 - 02/2008)

Related Diseases

1. Neoplasms (Cancer)
2. Melanoma (Melanoma, Malignant)
3. Choroidal Neovascularization
4. Hepatocellular Carcinoma (Hepatoma)
5. Neuroendocrine Tumors (Neuroendocrine Tumor)

Related Drugs and Biologics

1. Cyclophosphamide (Cytoxan)
2. DNA (Deoxyribonucleic Acid)
3. chromogranin A (344-364)
4. Interleukin-12 (IL 12)
5. Liposomes (Liposome)
6. Calreticulin
7. Angiogenesis Inhibitors
8. Peptides
9. Interferons
10. Amino Acids

Related Therapies and Procedures

1. Immunotherapy
2. Heterologous Transplantation (Xenotransplantation)
3. Injections